Torrent Pharma Share Price, Stock Analysis & Company Profile
Torrent Pharmaceuticals Limited (also referred to as Torrent Pharma) is a flagship company of the Torrent Group and a dominant player in the Indian Pharmaceuticals & Drugs Sector. Known for its strong presence in chronic therapeutic segments, the company has established itself as a leader in cardiovascular and central nervous system (CNS) therapies.
This page provides a comprehensive suite of tools for investors to track the Torrent Pharma share price, perform a detailed Torrent Pharmaceuticals stock analysis, and understand the company's growth in the global healthcare market.
About Torrent Pharmaceuticals Limited
Established in 1959 by Late Shri U. N. Mehta, Torrent Pharma is headquartered in Ahmedabad and has grown from a domestic firm into a global specialty pharmaceutical company. It operates in more than 40 countries, with significant market shares in India, Brazil, Germany, and the United States.
The company is distinguished by its focus on "Branded Generics" and its high R&D investment, which fuels its pipeline of complex formulations. Over the years, Torrent has successfully integrated major acquisitions, such as Unichem’s domestic business and Curatio Healthcare, to solidify its leadership in the Indian market.
Torrent Pharma Business Model
The company's business model is built on high-quality manufacturing and a focus on specialized therapy areas. Key operational pillars include:
-
Therapeutic Specialization: A leader in chronic therapies, including Cardiovascular (CV), Central Nervous System (CNS), Gastrointestinal (GI), and Vitamins Minerals Nutrients (VMN).
-
Global Branded Generics: Maintaining a strong front-end presence in regulated markets like Germany and Brazil, where it is among the top generic players.
-
Manufacturing Prowess: Operating state-of-the-art facilities across India and the US, many of which are approved by global regulatory bodies like the USFDA and EMA.
-
Research & Development: Investing significantly in its R&D centre to develop value-added medicines and new chemical entities.
-
Acquisition-Led Growth: A proven track record of acquiring and scaling brands to gain rapid entry into new therapeutic segments like dermatology and nephrology.
Torrent Pharma IPO and Listing Details
Torrent Pharma has been a long-standing wealth creator on the Indian stock exchanges, representing the steady growth of the domestic pharma industry.
- Listing Year: 1972 (Public Issue)
- IPO Price: Issued at a par value of Rs 100 during its initial capital raising in 1972.
- Face Value: Rs 5 per share (Post-split).
- ISIN: INE685A01028.
- NSE Symbol: TORNTPHARM.
- BSE Scrip Code: 500420.
Torrent Pharma Corporate Action History
The company has a consistent history of corporate actions designed to reward its shareholders and ensure liquidity in the market.
Bonus Share History
Torrent Pharma has issued bonus shares multiple times to reward long-term investors.
- 2022: 1:1 Bonus Issue (1 bonus share for every 1 share held).
- 2013: 1:1 Bonus Issue.
- 2006: 1:1 Bonus Issue.
Stock Split History
The company has adjusted its face value in the past to improve accessibility for retail investors.
- 2006: Stock split from a Face Value of Rs 10 to Rs 5.
- Ex-Date: 20 February 2006.
Dividend History
The company is known for its regular dividend payouts, often declaring both interim and final dividends in a single financial year.
-
FY 2025-26: Declared an interim dividend of Rs 29.00 per share.
-
FY 2024-25: Total dividends included payouts of Rs 26.00 and Rs 6.00 per share.
-
FY 2023-24: Total dividends included payouts of Rs 22.00 and Rs 6.00 per share.
Investor Resources Available on This Page
Retail investors can access specialised data in the respective tables on this page to conduct a professional Torrent Pharma stock analysis:
-
Price Chart: Track the historical price action and long-term performance of the Torrent Pharmaceuticals share price. (data delayed by 15 minutes)
-
Company Ratios: Review critical metrics like P/E ratio, ROCE, Operating Profit Margin, and Debt-to-Equity.
-
Quarterly Results: Monitor the latest sales growth and net profit margins every quarter.
-
Balance Sheet: Analyse the company’s capital structure and its investment in manufacturing assets.
-
Cash Flow Statement: Evaluate how the company generates cash to fund its R&D and dividend payouts.
-
Shareholding & Promoters: Track the stake held by the Mehta family and the participation of institutional investors.
-
Pros & Cons: A simplified summary of the company’s brand strength in chronic therapies versus regulatory risks.
-
Annual Reports: Download official company reports to understand the management's vision for the future of global healthcare.
Frequently Asked Questions (FAQs)
Q1. What is the latest Torrent Pharma share price?
The updated price is displayed at the top of this page. Please note that all price data and charts are subject to a 15-minute delay from the exchanges.
Q2. Who are the promoters of Torrent Pharmaceuticals?
The company is promoted by the Torrent Group, led by the Mehta family (Mr. Samir Mehta and Mr. Sudhir Mehta).
Q3. When was the last bonus issue for Torrent Pharma?
The most recent bonus issue took place in July 2022, where the company issued shares in a 1:1 ratio.
Q4. Does Torrent Pharma pay regular dividends?
Yes, the company has a strong track record of paying regular dividends. It typically declares an interim dividend in the second half of the financial year and a final dividend after the annual results.
Q5. Has Torrent Pharma ever split its shares?
Yes, the company last split its shares in February 2006, reducing the face value from Rs 10 to Rs 5 per share.
Q6. Where can I find the quarterly results for Torrent Pharma?
All quarterly financial statements, including consolidated revenue and EBITDA, are available in the "Quarterly Results" section on this page.
Q7. How can I download the Torrent Pharma Annual Report?
The latest and past Annual Reports can be accessed directly from the "Reports" or "Documents" section table provided on this page.